Related Experiment Video

Updated: Jul 13, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Postmarketing surveillance study of Norplant in developing countries

P Hannaford1

  • 1Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, AB25 2AY, Aberdeen, UK. p.hannaford@abdn.ac.uk

Lancet (London, England)
|June 19, 2001
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Collection of Alfalfa Root Exudates to Study the Impact of Di(2-ethylhexyl) Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di(2-ethylhexyl) Phthalate on Metabolite Production

Published on: June 2, 2023

Separation and Identification of Conventional Microplastics from Farmland Soils
14:10

Separation and Identification of Conventional Microplastics from Farmland Soils

Published on: March 21, 2025

Related Experiment Videos

Last Updated: Jul 13, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Collection of Alfalfa Root Exudates to Study the Impact of Di(2-ethylhexyl) Phthalate on Metabolite Production
06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di(2-ethylhexyl) Phthalate on Metabolite Production

Published on: June 2, 2023

Separation and Identification of Conventional Microplastics from Farmland Soils
14:10

Separation and Identification of Conventional Microplastics from Farmland Soils

Published on: March 21, 2025

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Articles linked to this work by shared authors, journal, and citation graph.

Structural changes to the brood pouch of male pregnant seahorses (Hippocampus abdominalis) facilitate exchange between father and embryos.

Placenta·2021

Perturbative optical parametric amplification in the extreme ultraviolet.

Nature communications·2015

Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial.

BJOG : an international journal of obstetrics and gynaecology·2014

Is the health of people living in rural areas different from those in cities? Evidence from routine data linked with the Scottish Health Survey.

BMC health services research·2012

Suppression of the internal electric field effects in ZnO/Zn(0.7)Mg(0.3)O quantum wells by ion-implantation induced intermixing.

Nanotechnology·2011

Temperature dependence of the universal contact parameter in a unitary Fermi gas.

Physical review letters·2011

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

International approval of Chinese pharmaceuticals: a USA-anchored analysis with comparative insights from Europe and other markets.

EClinicalMedicine·2026

Time trends and area-level socioeconomic inequalities in early childhood development at 2-2.5 years old in England between 2019 and 2025: a local area ecological study.

BMJ public health·2026

The impact of the global budget payment on healthcare fund expenditure in integrated delivery systems: evidence from China's county-level medical alliance reform.

Frontiers in public health·2026

Country-specific burden of type 2 diabetes mellitus in the Caribbean, 1990-2023: Insights from the global burden of disease study.

Diabetes research and clinical practice·2026

Burden and temporal trends attributable to low bone mineral density in Mexico, 1990-2023: a global burden of disease analysis.

Archives of osteoporosis·2026

[Analysis of influencing factors on the second dose of varicella vaccine for children aged 1-12 years in 10 provinces of China].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us